Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have one or more thyroid nodules that are at least partly solid and measure 5mm or larger, confirmed by a standard ultrasound scan
- You have already had a standard ultrasound, a contrast-enhanced ultrasound (an ultrasound using a special dye to show more detail), and a fine-needle biopsy (a procedure where a small needle is used to take a tissue sample) of your thyroid
- Your biopsy results have come back with a clear finding, confirming the nodule is either benign (non-cancerous) or malignant (cancerous)
Who may not be able to join:
- Your biopsy results fall into certain unclear or inconclusive categories (known as Bethesda I, III, or IV) and no clear benign or malignant diagnosis has been confirmed (confirm with trial site)
- You have previously had a thyroid ablation (a procedure to destroy thyroid tissue) or thyroid surgery
- The ultrasound images taken of your thyroid are not clear enough to be used in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jingliang Ruan, Ph.D., Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phone: +8613694202230
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Diagnostic performance; Unnecessary biopsy rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.